US Stock MarketDetailed Quotes

BDC Belden

Watchlist

115.630
+2.430+2.15%

Close Jan 3 16:00 ET

115.630
0.0000.00%

Post 16:34 ET

4.66BMarket Cap26.83P/E (TTM)

Belden Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Belden Q3 2024 Earnings Date

Currency：USDOct 31, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	643.71M	654.93M	+11.22M
Beat Est.	+2.70%	+4.49%	+1.74%
EPS	1.10	1.30	+0.20
Beat Est.	-35.29%	-23.53%	+18.18%

Analyst Rating

Strong Buy

Dec 31, 2024

Belden Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 634.446M	--
--	2024/Q4	-- / 654.439M	--
Oct 31, 2024	2024/Q3	654.926M / 643.711M	--
Aug 1, 2024	2024/Q2	604.336M / 574.184M	--
May 2, 2024	2024/Q1	535.675M / 513.686M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 634.446M--

--2024/Q4-- / 654.439M--

Oct 31, 20242024/Q3654.926M / 643.711M--

Aug 1, 20242024/Q2604.336M / 574.184M--

May 2, 20242024/Q1535.675M / 513.686M--

Unlock Free Earnings Estimates

Open Account

Belden Earnings Reports

Belden | 10-Q: Q3 2024 Earnings Report

Oct 31, 2024 13:11 ET

Belden | 8-K: Belden Reports Third Quarter 2024 Results

Oct 31, 2024 08:00 ET

Belden | 10-Q: Q2 2024 Earnings Report

Aug 1, 2024 12:06 ET

Belden | 8-K: Belden Reports Second Quarter 2024 Results

Aug 1, 2024 07:51 ET

Trending US Stocks

Symbol Mini Chart % Chg

DexCom

DXCM

+3.27%

Collegium Pharmaceutical

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 31, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data